ASSESSMENT OF COMMON ADVERSE EVENTS OF RELUGOLIX COMBINATION THERAPY IN PREMENOPAUSAL WOMEN TREATED FOR SYMPTOMATIC ESTROGEN-DRIVEN CONDITIONS: LIBERTY AND SPIRIT STUDIES

Ayman Al‐Hendy, Sawsan As‐Sanie, Juan Camilo Arjona Ferreira, Yulan Li, Rachel B Wagman, Linda C. Giudice
In: Fertility and Sterility · 2021 · vol. 116(3) , pp. e11 · doi:10.1016/j.fertnstert.2021.07.038 · W3199018729
article OA: closed CC0 ⤵ 1 in-corpus citation
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This paper assessed the common adverse events of relugolix combination therapy in premenopausal women with symptomatic estrogen-driven conditions, based on data from the LIBERTY and SPIRIT studies.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-09-17T06:32:46.214484+00:00
License: CC0 · commercial use OK